Page 10«..9101112..20..»

Self-repairing heart tissue breakthrough brings hope for cardiac … – ABC Online

By Sykes24Tracey

Updated March 17, 2017 13:31:00 Queensland researchers have used stem cells to create a beating human heart muscle, as well as heart tissue that is able to repair itself. Doctors James Hudson and Enzo Porello from the University of Queensland worked with German researchers to create the samples in a laboratory, and will use them to study cardiac biology and diseases.

To Read More: Self-repairing heart tissue breakthrough brings hope for cardiac … – ABC Online
categoriaCardiac Stem Cells commentoComments Off on Self-repairing heart tissue breakthrough brings hope for cardiac … – ABC Online | dataMarch 18th, 2017
Read All

Belgium’s Tigenix says heart attack stem cell trial successful – Reuters

By JoanneRUSSELL25

BRUSSELS Belgian biotech group Tigenix said on Monday its medical trial with a novel treatment for patients at risk of heart failure after a coronary attack was successful. The group said patients treated in its PhaseI/II trial of donor-derived expanded cardiac stem cells (AlloCSC) showed no side-effects and all of them continued to live after 30 days, six months and a year. Tigenix added that in one subgroup of trial patients associated with a poor long-term outlook, there was a larger reduction in the size of infarction, tissue death due to inadequate blood supply

To Read More: Belgium’s Tigenix says heart attack stem cell trial successful – Reuters
categoriaCardiac Stem Cells commentoComments Off on Belgium’s Tigenix says heart attack stem cell trial successful – Reuters | dataMarch 16th, 2017
Read All

Scientists create ‘beating’ human heart muscle for cardiac research – UQ News

By daniellenierenberg

Scientists at The University of Queensland have taken a significant step forward in cardiac disease research by creating a functional beating human heart muscle from stem cells. Dr James Hudson and Dr Enzo Porrello from the UQ School of Biomedical Sciences collaborated with German researchers to create models of human heart tissue in the laboratory so they can study cardiac biology and diseases in a dish.

To Read More: Scientists create ‘beating’ human heart muscle for cardiac research – UQ News
categoriaCardiac Stem Cells commentoComments Off on Scientists create ‘beating’ human heart muscle for cardiac research – UQ News | dataMarch 16th, 2017
Read All

Belgium’s Tigenix says heart attack stem cell trial successful – KFGO

By daniellenierenberg

Monday, March 13, 2017 3 a.m.

To Read More: Belgium’s Tigenix says heart attack stem cell trial successful – KFGO
categoriaCardiac Stem Cells commentoComments Off on Belgium’s Tigenix says heart attack stem cell trial successful – KFGO | dataMarch 15th, 2017
Read All

Woodrose Ventures Corporation Announces Proposed Acquisition … – Marketwired (press release)

By raymumme

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 13, 2017) - NOT FOR DISSEMINATION IN THE UNITED STATES Editors Note: There is a photo associated with this press release. Woodrose Ventures Corporation (TSX VENTURE:WRS.H) ("Woodrose" or the "Company") is pleased to announce that it has entered into an agreement (the "Agreement") dated March 10, 2017 to acquire all of the shares of Novoheart Holdings Ltd. ("Novoheart"), a global stem cell biotechnology company dedicated to human heart engineering (the "Transaction")

To Read More: Woodrose Ventures Corporation Announces Proposed Acquisition … – Marketwired (press release)
categoriaCardiac Stem Cells commentoComments Off on Woodrose Ventures Corporation Announces Proposed Acquisition … – Marketwired (press release) | dataMarch 14th, 2017
Read All

Daiichi Sankyo forges $12M pact for GPCR pain program with Heptares; Incyte shares jump on latest takeover chatter – Endpoints News

By JoanneRUSSELL25

Heptares struck a $12 million deal to partner with Daiichi Sankyo on a new GPCR pain drug. The UK biotech gets $4 million upfront and $8 million in research support along with an unspecified set of milestones for the deal, in which the Sosei subsidiary will search for new drugs that can be developed for pain.

To Read More: Daiichi Sankyo forges $12M pact for GPCR pain program with Heptares; Incyte shares jump on latest takeover chatter – Endpoints News
categoriaCardiac Stem Cells commentoComments Off on Daiichi Sankyo forges $12M pact for GPCR pain program with Heptares; Incyte shares jump on latest takeover chatter – Endpoints News | dataMarch 14th, 2017
Read All

VistaGen Therapeutics Inc. (Nasdaq: VTGN) to Ring The Nasdaq Stock Market Closing Bell – GlobeNewswire (press release)

By LizaAVILA

March 10, 2017 15:16 ET | Source: NASDAQ, Inc. ADVISORY, March 10, 2017 (GLOBE NEWSWIRE) -- What:VistaGen Therapeutics Inc. (Nasdaq:VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS) disorders, will visit the Nasdaq MarketSite in Times Square

To Read More: VistaGen Therapeutics Inc. (Nasdaq: VTGN) to Ring The Nasdaq Stock Market Closing Bell – GlobeNewswire (press release)
categoriaCardiac Stem Cells commentoComments Off on VistaGen Therapeutics Inc. (Nasdaq: VTGN) to Ring The Nasdaq Stock Market Closing Bell – GlobeNewswire (press release) | dataMarch 11th, 2017
Read All

Cardiac research nets Holly Mewhort prestigious heart association award – UCalgary News

By NEVAGiles23

Numerous people may say they want to grow up to be a heart surgeon, but very few actually achieve that goal.

To Read More: Cardiac research nets Holly Mewhort prestigious heart association award – UCalgary News
categoriaCardiac Stem Cells commentoComments Off on Cardiac research nets Holly Mewhort prestigious heart association award – UCalgary News | dataMarch 10th, 2017
Read All

TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial – P&T Community

By raymumme

TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial P&T Community Effective July 31, 2015, TiGenix acquired Coretherapix, whose lead cellular product candidate, AlloCSC-01, is currently in a Phase II clinical trial in Acute Myocardial Infarction (AMI). In addition, the second product candidate from the cardiac stem ... and more »

To Read More: TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial – P&T Community
categoriaCardiac Stem Cells commentoComments Off on TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial – P&T Community | dataMarch 10th, 2017
Read All

Robert Clayton Robbins Top Choice for UA President – Arizona Public Media

By Sykes24Tracey

Robert Clayton Robbins, head of the Texas Medical Center, was named Tuesday as top choice for president of the University of Arizona. The Board of Regents selected Robbins in Phoenix following interviews with him and one other candidate Monday. Robbins will meet the campus community and the public at a forum Wednesday afternoon.

To Read More: Robert Clayton Robbins Top Choice for UA President – Arizona Public Media
categoriaCardiac Stem Cells commentoComments Off on Robert Clayton Robbins Top Choice for UA President – Arizona Public Media | dataMarch 9th, 2017
Read All

Using Stem Cells to Predict Toxicity of Chemotherapy Drugs – ScienceBlog.com (blog)

By admin

A team of scientists has developed a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for their potential to damage patients hearts. The study, published in Science Translational Medicine, was co-authored by Paul Burridge, PhD, assistant professor of Pharmacology.

To Read More: Using Stem Cells to Predict Toxicity of Chemotherapy Drugs – ScienceBlog.com (blog)
categoriaCardiac Stem Cells commentoComments Off on Using Stem Cells to Predict Toxicity of Chemotherapy Drugs – ScienceBlog.com (blog) | dataMarch 7th, 2017
Read All

Stem Cell Therapy receives FDA Boost to enter the US Market – Labiotech.eu (blog)

By LizaAVILA

TiGenix has receivedpositive feedback from the FDA on an improved global phase III trial protocol for its lead candidateCx601 for Crohns disease. This is expected tospeed up US approval. TiGenix is a Belgian companydevelopingstem cell therapies

To Read More: Stem Cell Therapy receives FDA Boost to enter the US Market – Labiotech.eu (blog)
categoriaCardiac Stem Cells commentoComments Off on Stem Cell Therapy receives FDA Boost to enter the US Market – Labiotech.eu (blog) | dataMarch 7th, 2017
Read All

Opinion/Commentary: Global stem cell therapy market to showcase growth – The Daily Progress

By JoanneRUSSELL25

LONDON Technavio analysts forecast the global stem cell therapy market to grow at a compound annual growth rate of close to 37 percent during the forecast period, according to their latest report. The research study covers the present scenario and growth prospects of the global stem cell therapy market for 2017-2021. To determine the market size, the study considers revenue generated from allogenic and autogenic stem cell therapies

To Read More: Opinion/Commentary: Global stem cell therapy market to showcase growth – The Daily Progress
categoriaCardiac Stem Cells commentoComments Off on Opinion/Commentary: Global stem cell therapy market to showcase growth – The Daily Progress | dataMarch 5th, 2017
Read All

Heart Disease | Harvard Stem Cell Institute (HSCI)

By JoanneRUSSELL25

The Harvard Stem Cell Institute is developing new techniques to grow and transplant heart cells, replacing those lost to cardiovascular disease. The greatest threat to the long-term health and well-being of people living with diabetes is cardiovascular disease.

To Read More: Heart Disease | Harvard Stem Cell Institute (HSCI)
categoriaCardiac Stem Cells commentoComments Off on Heart Disease | Harvard Stem Cell Institute (HSCI) | dataMarch 5th, 2017
Read All

Stem cell therapy can help in treating diabetic heart disease – Business Standard

By LizaAVILA

Recent advancements in stem cells research have given hope for successfully treating diabetic heart disease (DHD), renowned New Zealand-based researcher in cardiovascular diseases Dr Rajesh Katare said on Tuesday. DHD affected the muscular tissues of the heart leading to complications and it had been demonstrated that resident stem cells of myocardium can be stimulated to repair and replace e degenerated cardiac myocytes resulting in a novel therapeutic effect and ultimately cardiac regeneration, he said.

To Read More: Stem cell therapy can help in treating diabetic heart disease – Business Standard
categoriaCardiac Stem Cells commentoComments Off on Stem cell therapy can help in treating diabetic heart disease – Business Standard | dataMarch 5th, 2017
Read All

Stem Cells and Aging | Life Code

By raymumme

Adult stem cell function declines with age leading to the decline in fitness The potential therapeutic use of stem cells is a very hot topic these days. Most of the attention has focused on embryonic stem cells and induced Pluripotent Stem cells (iPS cells), which can form every tissue type in the body to regenerate failing organs. The problem is that detailed knowledge is lacking for how to stimulate the embryonic stem cells to form differentiated tissues (e.g

To Read More: Stem Cells and Aging | Life Code
categoriaCardiac Stem Cells commentoComments Off on Stem Cells and Aging | Life Code | dataMarch 1st, 2017
Read All

Stem cell therapy can help treat diabetic heart disease – The … – Economic Times

By LizaAVILA

KARAIKAL: Recent advancements in stem cells research have given hope for successfully treating diabetic heart disease (DHD), renowned New Zealand-based researcher in cardiovascular diseases Dr Rajesh Katare said today.

To Read More: Stem cell therapy can help treat diabetic heart disease – The … – Economic Times
categoriaCardiac Stem Cells commentoComments Off on Stem cell therapy can help treat diabetic heart disease – The … – Economic Times | dataMarch 1st, 2017
Read All

Johns Hopkins Medicine, Maryland Stem Cell Research Fund and … – Business Wire (press release)

By daniellenierenberg

SAN CARLOS, Calif. & BALTIMORE--(BUSINESS WIRE)--Johns Hopkins Medicine, the Maryland Stem Cell Research Fund (MSCRF) and BioCardia, Inc. (OTC:BCDA) today announced that the first patient has been treated in the pivotal Phase III CardiAMP clinical trial of a cell-based therapy for the treatment of ischemic heart failure that develops after a heart attack.

To Read More: Johns Hopkins Medicine, Maryland Stem Cell Research Fund and … – Business Wire (press release)
categoriaCardiac Stem Cells commentoComments Off on Johns Hopkins Medicine, Maryland Stem Cell Research Fund and … – Business Wire (press release) | dataMarch 1st, 2017
Read All

TiGenix to present at Cowen’s 37th Annual Health Care Conference in Boston – EconoTimes

By LizaAVILA

Wednesday, March 1, 2017 6:01 AM UTC PRESS RELEASE TiGenix to present at Cowen's 37thAnnual Health Care Conference in Boston Leuven (BELGIUM) - 1st March, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG), an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, today announced that Eduardo Bravo, CEO of TiGenix, will be presenting at the 37th Annual Cowen and Company's Health Care Conference in Boston (USA) at The Boston Marriott Copley Place on Monday, March 6 at 3:20-3:50PM (EST) in Regis, 3rd Floor (breakout at 4:00 PM-04:30PM (EST) at Boston University, 3rd Floor). The presentation will be webcast live and can be accessed on the day of the event at this link. A replay of the webcast will be available on the Company's website for 30 days following the presentation

To Read More: TiGenix to present at Cowen’s 37th Annual Health Care Conference in Boston – EconoTimes
categoriaCardiac Stem Cells commentoComments Off on TiGenix to present at Cowen’s 37th Annual Health Care Conference in Boston – EconoTimes | dataMarch 1st, 2017
Read All

StemBioSys Lands Experimental UT Tech That Finds Young Stem Cells – Xconomy

By Sykes24Tracey

Xconomy Texas San Antonio StemBioSys, the life sciences company with a system for growing stem cells, has licensed an experimental technology from University of Texas Health San Antonio that may help identify healthy young adult stem cells among large pools of other cells. Theres plenty of research examining how to possibly use adult stem cells as treatments for medical conditions, ranging from cardiac disease to metabolic disorders, but current uses are rather limited to therapies like bone-marrow transplants for blood disorders, especially in children.

To Read More: StemBioSys Lands Experimental UT Tech That Finds Young Stem Cells – Xconomy
categoriaCardiac Stem Cells commentoComments Off on StemBioSys Lands Experimental UT Tech That Finds Young Stem Cells – Xconomy | dataMarch 1st, 2017
Read All